Chemotherapy Consent/Assent Discussion Note (Pediatric Oncology)

Documents the informed consent and assent conversation for initiating chemotherapy in a pediatric patient, covering treatment plan, material risks, alternatives, fertility counseling, and the child's assent with legally…

Document Type

clinical note / Progress Note

Specialties

Pediatric Oncology
Created by Augustun

Template Preview

Date/Time of Discussion: [Date and time]

Setting: [inpatient / clinic / infusion center / telehealth]

Participants: [Patient; parent(s)/guardian(s) with relationship; care team members present]

Interpreter: [Interpreter used: language, modality / Not used / Not applicable]

Consent Provided By: [Name, relationship, legal authority]

Clinical Context and Treatment Plan

[Clinical context and treatment summary] (3–5 sentences covering: working diagnosis with relevant qualifiers such as stage, risk group, or relapse/refractory status; treatment intent [curative / disease control / symptom palliation]; regimen or protocol name and whether on or off trial; route(s) and general schedule/duration; urgency of initiation; key supportive requirements anticipated such as central line, transfusions, hospitalizations, or sedation for procedures.)

Consent Discussion

[Narrative summary of discussion] (Document that the clinician explained the proposed treatment in understandable terms, that the decision was voluntary, and that questions were invited and answered. Emphasize patient/family-specific concerns addressed.)

Benefits/Goals: [Expected benefits aligned with treatment intent, acknowledging uncertainty as appropriate]

Material Risks Discussed: (Document categories actually discussed; highlight regimen-specific toxicities.)

  • Common burdens: [Nausea, fatigue, alopecia, mucositis, etc. as discussed]
  • Hematologic/infection risk: [Myelosuppression, transfusion needs, infection risk; fever/ED return triggers reviewed]
  • Organ toxicities: [Cardiac / renal / hepatic / neurologic / ototoxicity / other as applicable to agents]
  • Infusion/hypersensitivity reactions: [Risk and monitoring reviewed]

Long-Term/Late Effects: [Late effects reviewed as relevant: fertility/endocrine, cardiac, neurocognitive, secondary malignancy] (Note that late-effects counseling is ongoing.)

Alternatives Discussed: [Alternatives reviewed including different regimen, clinical trial, delayed start, supportive/palliative care only, second opinion, and no treatment with expected consequences]

Comprehension: [Evidence of understanding: teach-back, guardian summary, questions asked and answered; note any persistent concerns or need for additional support]

Fertility and Reproductive Health Counseling

[Fertility counseling summary] (Document that fertility risk was discussed in developmentally appropriate terms.)

  • Pubertal/reproductive status: [Prepubertal / peripubertal / postpubertal; pregnancy potential if relevant]
  • Preservation options reviewed: [Options discussed with feasibility, timing constraints]
  • Family/patient decision: [Interested / uncertain / declined]
  • Referral: [Offered / placed / deferred] (Include timing relative to chemotherapy start.)
  • Pregnancy testing/teratogenic counseling: [Status and contraception recommendations if applicable]
  • If deferred: [Reason and specific plan to revisit] (Required if counseling not completed.)

Assent Discussion

[Summary of developmentally appropriate conversation with patient] (Describe what the child/adolescent was told; include brief direct quote if helpful.)

  • Patient understanding: [Clinician assessment of comprehension]
  • Voluntariness: [Absence of coercion noted]
  • Assent status: [Assented / neutral / objected / not sought]
  • If dissented: [Concerns expressed; supportive steps taken; rationale if treatment proceeds; ethics consultation considered]
  • If not sought: [Reason and plan to engage when feasible]

Consent Outcome and Documentation

  • Decision: [Proceed / defer / decline]
  • Consent type: [Written consent signed / verbal consent per institutional policy]
  • Signed by: [Name, relationship, date/time]
  • Document location: [Scanned to EHR / e-consent platform / paper chart]
  • Education materials provided: [Titles/types provided; note language if non-English]
  • Next steps: [Immediate plan: admission, line placement, first dose timing, fertility referral, follow-up for deferred items]

(If any required element was not completed—fertility counseling, assent—explicitly state the reason and plan to address. Do not leave gaps without explanation.)

Want to use this template?

Copy it into your workflow, or book a demo to see Augustun draft notes like this automatically.